Kathleen Camilla Piens

Title: Kathleen Camilla Piens: Innovator in Molecular Treatment

Introduction

Kathleen Camilla Piens is a notable inventor based in Belgium. She has made significant contributions to the field of molecular treatment, particularly in relation to Pompe's disease. Despite having no patents registered under her name, her work has been influential in advancing medical research.

Latest Patents

Her latest patents include "Methods And Materials For Treatment Of Pompe's Disease," which relates to molecular complexes that possess acid alpha-glucosidase activity. This document highlights modifications that enhance the ability of these molecular complexes to be transported into mammalian cells. Another significant patent is "Hydrolysis Of Mannose-1-Phospho-6-Mannose Linkage To Phospho-6-Mannose." This patent describes methods and genetically engineered cells that are useful for uncapping a mannose-6-phosphate residue on an oligosaccharide by utilizing a mannosidase capable of hydrolyzing the mannose-1-phospho-6-mannose linkage to phospho-6-mannose.

Career Highlights

Throughout her career, Kathleen has worked with various companies, including Oxyrane UK Limited and Vib Vzw. Her experience in these organizations has allowed her to develop her expertise in molecular treatment and contribute to innovative solutions in the medical field.

Collaborations

Some of her notable coworkers include Wouter Vervecken and Nico Luc Callewaert. Their collaboration has likely played a role in advancing the research and development of her innovative ideas.

Conclusion

Kathleen Camilla Piens is a dedicated inventor whose work in molecular treatment has the potential to impact the lives of many. Her contributions, although not yet reflected in a number of patents, demonstrate her commitment to advancing medical science.